Jonathan A. Baker
6Patents
4h-index
13Co-inventors
50Inventor score
Filing activity: Feb 24, 2011 → Dec 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9186337B2 | Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae | Human Necessities | 26 | Active |
| US9616058B2 | Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use | Emerging Cross-Sectional Technologies | 7 | Active |
| US9790196B2 | Lysine demethylase inhibitors for diseases and disorders associated with Flaviviridae | Emerging Cross-Sectional Technologies | 6 | Active |
| US9908859B2 | Lysine demethylase inhibitors for myeloproliferative disorders | Chemistry; Metallurgy | 5 | Active |
| US12150945B2 | Liver disease | Physics | 0 | Active |
| US12097207B1 | Liver disease | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.